Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose finasteride and dutasteride reduce PSA levels by 27.8% in men with male androgenetic alopecia.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Dutasteride may lower the chance of finding prostate cancer in men with enlarged prostates.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

Dutasteride for hair loss might increase the risk of a rare stroke type.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

The letter is skeptical about the effectiveness of anti-androgen therapy for COVID-19 and calls for strong evidence from clinical trials.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

Hair restoration techniques like follicular unit transplant surgery and follicular unit extraction are effective, with ideal graft placement density between 20-30 units per cm². Medications like Minoxidil and Finasteride can help maintain and regrow hair.

The new treatment regimen was effective in promoting significant hair growth in all 15 male patients with androgenic alopecia.

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.

Finasteride increases hair count and improves hair growth with low risk of side effects.

Plant-based chemicals may help hair growth and prevent hair loss but need more research to compete with current treatments.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.

Large prostates link to more hair loss.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

Frontal fibrosing alopecia may affect nails and could be a type of lichen planus, treatable with certain medications.

Older patients sticking to their prostate medication saw lasting health benefits.

Natural products and phytochemicals may help with hair regrowth, but more research is needed.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Bioengineered nanoparticles can effectively treat hair loss by targeting specific enzymes and receptors.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

Men on 5-alpha-reductase inhibitors might have worse COVID-19 outcomes.

A new microneedle patch treats hair loss effectively with fewer side effects and less frequent use.